Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation.
Saved in:
| Title: | Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. |
|---|---|
| Authors: | Ravussin E; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Sanchez-Delgado G; Pennington Biomedical Research Center, Baton Rouge, LA, USA; Department of Medicine, Division of Endocrinology, Center de Recherche du Center Hospitalier de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada; Sport and Health University Research Institute and Institute of Nutrition and Food Technology 'José Mataix', University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria Ibs. Granada, Granada, Spain; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain., Martin CK; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Beyl RA; Pennington Biomedical Research Center, Baton Rouge, LA, USA., Greenway FL; Pennington Biomedical Research Center, Baton Rouge, LA, USA., O'Farrell LS; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Roell WC; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Qian HR; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Li J; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Nishiyama H; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Haupt A; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Pratt EJ; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Urva S; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA., Milicevic Z; Eli Lilly and Company, Vienna, Austria., Coskun T; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. Electronic address: coskun_tamer@lilly.com. |
| Source: | Cell metabolism [Cell Metab] 2025 May 06; Vol. 37 (5), pp. 1060-1074.e4. Date of Electronic Publication: 2025 Apr 08. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101233170 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1932-7420 (Electronic) Linking ISSN: 15504131 NLM ISO Abbreviation: Cell Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40203836 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Ravussin+E%22">Ravussin E</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22Sanchez-Delgado+G%22">Sanchez-Delgado G</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA; Department of Medicine, Division of Endocrinology, Center de Recherche du Center Hospitalier de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada; Sport and Health University Research Institute and Institute of Nutrition and Food Technology 'José Mataix', University of Granada, Granada, Spain; Instituto de Investigación Biosanitaria Ibs. Granada, Granada, Spain; CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martin+CK%22">Martin CK</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22Beyl+RA%22">Beyl RA</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22Greenway+FL%22">Greenway FL</searchLink>; Pennington Biomedical Research Center, Baton Rouge, LA, USA.<br /><searchLink fieldCode="AU" term="%22O'Farrell+LS%22">O'Farrell LS</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Roell+WC%22">Roell WC</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Qian+HR%22">Qian HR</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Nishiyama+H%22">Nishiyama H</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Haupt+A%22">Haupt A</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Pratt+EJ%22">Pratt EJ</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Urva+S%22">Urva S</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA.<br /><searchLink fieldCode="AU" term="%22Milicevic+Z%22">Milicevic Z</searchLink>; Eli Lilly and Company, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Coskun+T%22">Coskun T</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN, USA. Electronic address: coskun&#95;tamer@lilly.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101233170%22">Cell metabolism</searchLink> [Cell Metab] 2025 May 06; Vol. 37 (5), pp. 1060-1074.e4. <i>Date of Electronic Publication: </i>2025 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101233170 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1932-7420 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215504131%22">15504131 </searchLink><i>NLM ISO Abbreviation: </i>Cell Metab <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40203836 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.cmet.2025.03.011 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1060 Titles: – TitleFull: Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Ravussin E – PersonEntity: Name: NameFull: Sanchez-Delgado G – PersonEntity: Name: NameFull: Martin CK – PersonEntity: Name: NameFull: Beyl RA – PersonEntity: Name: NameFull: Greenway FL – PersonEntity: Name: NameFull: O'Farrell LS – PersonEntity: Name: NameFull: Roell WC – PersonEntity: Name: NameFull: Qian HR – PersonEntity: Name: NameFull: Li J – PersonEntity: Name: NameFull: Nishiyama H – PersonEntity: Name: NameFull: Haupt A – PersonEntity: Name: NameFull: Pratt EJ – PersonEntity: Name: NameFull: Urva S – PersonEntity: Name: NameFull: Milicevic Z – PersonEntity: Name: NameFull: Coskun T IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 05 Text: 2025 May 06 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1932-7420 Numbering: – Type: volume Value: 37 – Type: issue Value: 5 Titles: – TitleFull: Cell metabolism Type: main |
| ResultId | 1 |